MedTrace Logo

Stem Cells From Human Exfoliated Teeth in Treatment of Diabetic Patients With Significantly Reduced Islet Function

NCT03912480 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-04-22

No results posted yet for this study

Summary

To evaluate the safety and efficacy of Stem cells from human exfoliated teeth transplantation in patients with Islet function decreased significantly to provides scientific basis for further clinical studies to verify the safety and efficacy. On the basis of maintaining the original treatment, intravenous drip of dental pulp mesenchymal stem cells.

Conditions

  • Type1diabetes

Interventions

BIOLOGICAL

Stem cells from human exfoliated teeth

Intravenous infusion of pulp mesenchymal stem cells

Sponsors & Collaborators

  • CAR-T (Shanghai) Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Qin Huang, Doctor · Changhai houspital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-05
Primary Completion
2020-12-30
Completion
2021-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03912480 on ClinicalTrials.gov